Danish pharmaceutical giant Novo Nordisk, a leading player in diabetes care in China, has expressed strong confidence in the Chinese market. The company's chairman praised China's efforts and future plans in the healthcare sector.
CHOOSE YOUR LANGUAGE
互联网新闻信息许可证10120180008
Disinformation report hotline: 010-85061466